The safety data base from clinical trials comprised 2’ 737 CKD patients, including 1’ 789 patients treated with MIRCERA and 948 with another ESA.
Kliiniliste uuringute ohutusandmebaas hõlmab 2737 kroonilise neeruhaigusega patsienti, sealhulgas 1789 MIRCERA- ravi saanud ja 948 ESA- ravi saanud patsienti.